154 related articles for article (PubMed ID: 23975748)
1. The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases.
Spink C; Stege G; Tenbrock K; Harendza S
Nephrol Dial Transplant; 2013 Nov; 28(11):2800-5. PubMed ID: 23975748
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP; Chhabra P; Narayan G; Srivastava P; Prasad R; Singh A; Abhinay A; Batra VV
Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria.
Jacob M; Ohl K; Goodarzi T; Harendza S; Eggermann T; Fitzner C; Hilgers RD; Bolte A; Floege J; Rauen T; Tenbrock K
Kidney Blood Press Res; 2018; 43(2):360-366. PubMed ID: 29539619
[TBL] [Abstract][Full Text] [Related]
4. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
5. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the transcriptional regulation of the human MT1-MMP gene and association of risk reduction for focal-segmental glomerulosclerosis with two functional promoter SNPs.
Munkert A; Helmchen U; Kemper MJ; Bubenheim M; Stahl RA; Harendza S
Nephrol Dial Transplant; 2009 Mar; 24(3):735-42. PubMed ID: 18927121
[TBL] [Abstract][Full Text] [Related]
9. The association of cytotoxic T-lymphocyte antigen-4 + 49A/G and CT60 polymorphisms with type 1 diabetes and latent autoimmune diabetes in Chinese adults.
Jin P; Xiang B; Huang G; Zhou Z
J Endocrinol Invest; 2015 Feb; 38(2):149-54. PubMed ID: 25185645
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.
Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D
Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
[TBL] [Abstract][Full Text] [Related]
12. Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
Patel H; Mansuri MS; Singh M; Begum R; Shastri M; Misra A
PLoS One; 2016; 11(3):e0149441. PubMed ID: 26963610
[TBL] [Abstract][Full Text] [Related]
13. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
14. Association between CTLA-4 gene polymorphism and ankylosing spondylitis: a case-control study.
Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
Int J Clin Exp Pathol; 2015; 8(6):7421-5. PubMed ID: 26261646
[TBL] [Abstract][Full Text] [Related]
15. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
Oliveira VB; Dezan MR; Gomes FCA; Menosi Gualandro SF; Krieger JE; Pereira AC; Marsiglia JD; Levi JE; Rocha V; Mendrone-Junior A; Sabino EC; Dinardo CL
Int J Immunogenet; 2017 Oct; 44(5):219-224. PubMed ID: 28815969
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
18. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
19. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
[TBL] [Abstract][Full Text] [Related]
20. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Yoshio T; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
